Acceleron Pharma
XLRN
#1878
Rank
A$16.31 B
Marketcap
A$266.75
Share price
0.00%
Change (1 day)
13,896.63%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: A$16.31 Billion

As of January 2026 Acceleron Pharma has a market cap of A$16.31 Billion. This makes Acceleron Pharma the world's 1878th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022A$16.06 B6.54%
2021A$15.07 B50.41%
2020A$10.02 B149.2%
2019A$4.02 B40.67%
2018A$2.85 B16.3%
2017A$2.45 B84.01%
2016A$1.33 B-40.07%
2015A$2.22 B44.42%
2014A$1.54 B22.68%
2013A$1.25 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
A$264.35 B 1,520.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$119.27 B 631.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$785.77 B 4,716.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A$31.19 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.21 B-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
A$72.62 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$217.04 B 1,230.46%๐Ÿ‡บ๐Ÿ‡ธ USA